PL355453A1 - Pharmaceutical agent - Google Patents
Pharmaceutical agentInfo
- Publication number
- PL355453A1 PL355453A1 PL02355453A PL35545302A PL355453A1 PL 355453 A1 PL355453 A1 PL 355453A1 PL 02355453 A PL02355453 A PL 02355453A PL 35545302 A PL35545302 A PL 35545302A PL 355453 A1 PL355453 A1 PL 355453A1
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical agent
- pharmaceutical
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL355453A PL191525B1 (en) | 2002-08-12 | 2002-08-12 | Pharmaceutical agent |
PCT/PL2002/000076 WO2004014396A1 (en) | 2002-08-12 | 2002-10-24 | Medicament comprising fluocinolone and dexamethasone and/or hydrocortisone and gentamicin and/or neomycin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL355453A PL191525B1 (en) | 2002-08-12 | 2002-08-12 | Pharmaceutical agent |
Publications (2)
Publication Number | Publication Date |
---|---|
PL355453A1 true PL355453A1 (en) | 2004-02-23 |
PL191525B1 PL191525B1 (en) | 2006-06-30 |
Family
ID=31713223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL355453A PL191525B1 (en) | 2002-08-12 | 2002-08-12 | Pharmaceutical agent |
Country Status (2)
Country | Link |
---|---|
PL (1) | PL191525B1 (en) |
WO (1) | WO2004014396A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITBA20110004A1 (en) * | 2011-02-07 | 2012-08-08 | Francesco Decenvirale | "OINTMENT FOR THE TREATMENT OF SKIN INFLAMMATORY STATES AND ITS PROCESS OF MANUFACTURING" |
CN103450295A (en) * | 2013-08-28 | 2013-12-18 | 南阳普康药业有限公司 | Method for purifying gentamicin sulphate |
CN105169462B (en) * | 2015-10-22 | 2017-10-17 | 江苏科技大学 | Improve the mixed method of neomycinsulphate dispersing uniformity in vaseline |
US20200397720A1 (en) * | 2019-06-23 | 2020-12-24 | Charles Huntington Gallina | Method and formulation for treatment of wounds by new tissue regeneration with reduced trauma and scar tissue formation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1010363A (en) * | 1973-08-09 | 1977-05-17 | Albert M. Kligman | Topical composition comprising a corticosteroid and vitamin a acid |
YU46838B (en) * | 1986-02-14 | 1994-06-24 | Pero Dr. Višnjić | PROCEDURE FOR OBTAINING PREPARATIONS FOR THE TREATMENT OF PSORIASIS SKIN DISEASE |
-
2002
- 2002-08-12 PL PL355453A patent/PL191525B1/en not_active IP Right Cessation
- 2002-10-24 WO PCT/PL2002/000076 patent/WO2004014396A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2004014396A9 (en) | 2004-04-08 |
PL191525B1 (en) | 2006-06-30 |
WO2004014396A1 (en) | 2004-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0218625D0 (en) | Pharmaceutical compounds | |
GB0210397D0 (en) | Pharmaceutical formulations | |
AU2003291103A8 (en) | Pharmaceutical composition | |
IL164547A0 (en) | Pharmaceutical composition | |
AU2003250372A8 (en) | Pharmaceutical composition | |
GB0215775D0 (en) | Pharmaceutical compounds | |
HUP0303948A2 (en) | Solid orally-dispersible pharmaceutical formulation | |
GB2392093B (en) | Pharmaceutical formulations | |
GB0206505D0 (en) | Pharmaceutical combination | |
PL397022A1 (en) | Therapeutic agent | |
HK1065477A1 (en) | Pharmaceutical composition | |
PL373409A1 (en) | Pharmaceutical combination | |
GB0201520D0 (en) | Pharmaceutical uses | |
GB0316889D0 (en) | Pharmaceutical agents | |
PL355453A1 (en) | Pharmaceutical agent | |
GB0204392D0 (en) | Pharmaceutical compound | |
AU2003238900A8 (en) | Pharmaceutical formulation | |
GB0217703D0 (en) | Pharmaceutical composition | |
GB0224680D0 (en) | Pharmaceutical | |
GB0220451D0 (en) | Pharmaceutical use | |
GB0210240D0 (en) | Pharmaceutical combination | |
GB0225041D0 (en) | Pharmaceutical formulation | |
GB0214491D0 (en) | Pharmaceutical composition | |
GB0213305D0 (en) | Pharmaceutical composition | |
GB0227342D0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Decisions on the lapse of the protection rights |
Effective date: 20090812 |